PMVP
Pmv Pharmaceuticals Inc
1.30$
-2.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.4% | -6.1% | +0.3% | -5.9% | -14.4% | -10.8% | -10.4% | -12.4% | -12.9% | -17.2% | -15.0% | |
| – | +1.0% | -2.4% | +8.1% | -13.3% | -7.4% | -6.9% | -11.1% | -8.9% | -13.0% | -16.9% | -15.0% | |
| – | -27.6% | +26.4% | +1.8% | +0.6% | -16.3% | +25.6% | -14.1% | -17.7% | +4.5% | +3.0% | -68.1% | |
| – | +0.6% | -2.5% | +7.6% | -14.1% | -7.3% | -5.4% | -11.3% | -9.2% | -12.6% | -17.2% | -15.1% | |
| – | +13.0% | -8.6% | -4.0% | +10.2% | -40.6% | -31.0% | +16.7% | +4.9% | -7.7% | -27.5% | +23.0% | |
| – | +30.9% | -14.0% | -5.6% | +19.1% | +6.0% | -32.1% | +18.9% | +6.0% | -7.2% | -24.7% | +23.0% | |
| – | – | +3.3% | +30.8% | +8.0% | -71.7% | +3.4% | +3.6% | +3.4% | +3.3% | -27.3% | -25.9% | |
| – | +92.9% | -73.5% | +427.7% | -54.5% | +218.9% | -45.4% | -27.7% | +30.8% | -7.2% | -48.3% | +23.9% | |
| – | -5.0% | -5.8% | +0.8% | -7.7% | -11.0% | -9.1% | -12.2% | -13.9% | -13.5% | -16.0% | -18.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.9% | +0.0% | +0.1% | +0.2% | +0.0% | +0.7% | +0.1% | +1.9% | +0.5% | +0.1% | +0.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.